Ultragenyx Pharmaceutical Total Long Term Liabilities 2012-2024 | RARE
Ultragenyx Pharmaceutical total long term liabilities for the quarter ending June 30, 2024 were $0.913B, a 2.64% decline year-over-year.
- Ultragenyx Pharmaceutical total long term liabilities for 2023 were $0.935B, a 0.37% increase from 2022.
- Ultragenyx Pharmaceutical total long term liabilities for 2022 were $0.932B, a 122.66% increase from 2021.
- Ultragenyx Pharmaceutical total long term liabilities for 2021 were $0.418B, a 0.7% increase from 2020.